Cytokine adsorption in patients with acute‐on‐chronic liver failure (CYTOHEP)—A single center, open‐label, three‐arm, randomized, controlled intervention pilot trial

To investigate the efficacy of bilirubin reduction by hemoadsorption with CytoSorb® in patients with acute-on-chronic liver failure (ACLF) receiving continuous renal replacement therapy (CRRT).